Albany College of Pharmacy and Health Sciences at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
Albany College of Pharmacy and Health Sciences brings 2 presentations to IDWeek 2026 in Washington. Its program centres on drug-resistant Pseudomonas aeruginosa and how well specific antibiotics work against it. One lab study tests high-dose imipenem-relebactam with aztreonam against MBL-producing strains in a hollow fiber infection model.
| Organization | IDWeek 2026 Attendance |
|---|---|
Poster Thu Oct 22 12:15pm–1:30pm Activity of High-Dose Imipenem/Relebactam (i/R) Plus Aztreonam (ATM) Against MBL-Producing Pseudomonas aeruginosa (PSA) in a Hollow Fiber Infection Model (HFIM) Poster Thu Oct 22 12:15pm–1:30pm Ceftolozane/Tazobactam (C/T) and Ceftazidime/Avibactam (CZA) Non-susceptibility (NS) Among Hospitalized Adults with Pseudomonas aeruginosa (PSA) Isolated from Lower Respiratory Tract (LTR) Clinical Cultures: Index and Subsequent Episodes in the Kaiser Permanente Southern California (KPSC) System |
Instantly find 20 buyers from Albany College of Pharmacy and Health Sciences
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction